JAM3 promotes cervical cancer metastasis by activating the HIF-1α/VEGFA pathway
Article in BMC Women's Health (May 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
JAM3 is a potential risk biomarker for predicting prognosis and immune cell infiltration by regulating epithelial–mesenchymal transition in bladder cancer
Article in Biomolecules and Biomedicine (February 2024)
Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer.
Article in PeerJ (January 2024)